Research Article

The Association of Donor Thyroid Hormone Supplementation on Heart Transplant Recipient Survival

Table 1

Participant characteristics.

Overall (N = 46542)No THS (N = 17631)THS (N = 28911) value

Recipient LOS21.41 (25.06)21.18 (24.75)21.55 (25.25)0.124
Ischemic time3.25 (1.07)3.30 (1.08)3.22 (1.06)<0.001
Distance188.16 (217.90)192.52 (219.61)185.50 (216.80)0.001
Age52.75 (12.71)52.59 (12.77)52.86 (12.67)0.027
Nonwhite recipient15076 (32%)5692 (32%)9384 (32%)0.697
BMI27.24 (4.91)27.16 (4.89)27.29 (4.92)0.003
Region
 Region 11989 (4%)998 (6%)991 (3%)<0.001
 Region 25576 (12%)1479 (8%)4097 (14%)
 Region 35573 (12%)2400 (14%)3173 (11%)
 Region 44805 (10%)1727 (10%)3078 (11%)
 Region 57474 (16%)3388 (19%)4086 (14%)
 Region 61447 (3%)406 (2%)1041 (4%)
 Region 74093 (9%)2100 (12%)1993 (7%)
 Region 82799 (6%)968 (5%)1831 (6%)
 Region 93131 (7%)1040 (6%)2091 (7%)
 Region 103886 (8%)1259 (7%)2627 (9%)
 Region 115769 (12%)1866 (11%)3903 (14%)
VAD
 No VAD26369 (57%)9471 (54%)16898 (58%)<0.001
 LVAD13773 (30%)4667 (26%)9106 (31%)
 RVAD108 (0%)44 (0%)64 (0%)
 TAH339 (1%)86 (0%)253 (1%)
 LVAD + RVAD971 (2%)329 (2%)642 (2%)
 Unspecified1374 (3%)815 (5%)559 (2%)
 Unknown3608 (8%)2219 (13%)1389 (5%)
ECMO904 (2%)336 (2%)568 (2%)0.655
IABP5006 (11%)1983 (11%)3023 (10%)0.008
Creatinine1.27 (0.64)1.28 (0.71)1.26 (0.60)0.003
Total bilirubin1.09 (1.89)1.12 (2.03)1.06 (1.79)0.001
PRA4.18 (14.69)4.59 (15.75)3.58 (12.95)0.007
Diabetic recipient12080 (26%)4389 (25%)7691 (27%)<0.001
Days on waiting list216.85 (378.88)219.70 (379.27)215.11 (378.64)0.205
Gender matching
 Male donor to male recipient28054 (60%)10445 (59%)17609 (61%)0.001
 Female donor to female recipient7039 (15%)2728 (15%)4311 (15%)
 Female donor to male recipient6556 (14%)2601 (15%)3955 (14%)
 Male donor to female recipient4893 (11%)1857 (11%)3036 (11%)

Means (standard deviations) are presented for continuous variables. Counts (%) are presented for categorical variables. LOS: length of stay; BMI: body mass index; ECMO: extracorporeal membrane oxygenation; IABP: intra-aortic balloon pump; PRA: panel reactive antibodies; THS: thyroid hormone supplementation.